Page last updated: 2024-11-03

riluzole and Hearing Loss

riluzole has been researched along with Hearing Loss in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.

Research Excerpts

ExcerptRelevanceReference
"This study tests whether riluzole, a glutamate release inhibitor, and dimethylsulfoxide (DMSO), an anti-inflammatory and antioxidant solvent with favorable properties at the level of glutamate receptors, can protect against early-stage hearing loss in a mouse model of ELH."3.76Pharmacological protection of hearing loss in the mouse model of endolymphatic hydrops. ( Alagramam, KN; Frankel, JK; Heddon, CM; Levitt, AH; Megerian, CA; Melki, SJ; Momin, SR, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melki, SJ1
Heddon, CM1
Frankel, JK1
Levitt, AH1
Momin, SR1
Alagramam, KN1
Megerian, CA1
Guitton, MJ1
Wang, J1
Puel, JL1

Other Studies

2 other studies available for riluzole and Hearing Loss

ArticleYear
Pharmacological protection of hearing loss in the mouse model of endolymphatic hydrops.
    The Laryngoscope, 2010, Volume: 120, Issue:8

    Topics: Animals; Dimethyl Sulfoxide; Disease Models, Animal; Endolymphatic Hydrops; Hearing Loss; Mice; Neur

2010
New pharmacological strategies to restore hearing and treat tinnitus.
    Acta oto-laryngologica, 2004, Volume: 124, Issue:4

    Topics: Animals; Apoptosis; Disease Models, Animal; Hair Cells, Auditory; Hearing Loss; JNK Mitogen-Activate

2004